 |
Triphenylantimony Sulfide
|
(C6H5)3SbS
3958-19-8 |
| Product |
Product Code |
Order or Specifications |
99% Triphenylantimony Sulfide |
|
 |
99.5% Triphenylantimony Sulfide |
|
 |
99.9% Triphenylantimony Sulfide |
|
 |
99.95% Triphenylantimony Sulfide |
|
 |
99.99% Triphenylantimony Sulfide |
SB-OM7-04 |
 |
99.999% Triphenylantimony Sulfide |
|
 |
|
Triphenylantimony Sulfide is one of numerous organo-metallic compounds sold by American Elements under the tradename AE Organo-Metallics™ for uses requiring non-aqueous solubility such as recent solar energy and water treatment applications. Similar results can sometimes also be achieved with Nanoparticles (also see Nanotechnology and Quantum Dots) and by thin film deposition. Note American Elements additionally supplies many materials as solutions. Triphenylantimony Sulfide is generally immediately available in most volumes. High purity, submicron and nanopowder forms may be considered. Additional technical, research and safety information is available.
Antimony is a Block P, Group 15, Period 5 element. The electronic configuration is [Kr] 4d10 5s2 5p3. In its elemental form antimony's CAS number is 7440-36-0. The antimony atom has a radius of 145.pm and it's Van der Waals radius is 200.pm. Antimony is finding use in semiconductor technology for making infrared detectors, diodes and Hall-effect devices in crystalline structures, such as antimony telluride and gallium antimonide. Antimony is however a poor conductor of heat and electricity. It greatly increases the hardness and mechanical strength of lead. This has found applications in batteries, antifriction alloys, small arms and tracer bullets and cable sheathing. |
| Formula |
CAS No. |
Appearance |
Molecular Weight |
| (C6H5)3SbS |
3958-19-8 |
|
385.13
| |
|
© 2001-2008. American Elements is a U.S. Registered Trademark. All rights reserved.
This website and all pages, designs, concepts, logos, and color schemes herein are
the copyrighted proprietary rights and intellectual property of American Elements. |
|
Recent Research & Development for Antimony
- Simultaneous speciation of inorganic selenium and antimony in water samples by electrothermal vaporization inductively coupled plasma mass spectrometry following selective cloud point extraction.
Water Res. 2007 Sep 11; [Epub ahead of print]
- An antimony analogue of the molecular magnet [V15As6O42(H2O)]6-.
Dalton Trans. 2007 Aug 14;(30):3221-3. Epub 2007 Jul 6.
- Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate & miltefosine.
Indian J Med Res. 2007 Jul;126(1):73-5.
- Mucosal leishmaniasis Current scenario and prospects for treatment.
Acta Trop. 2007 Aug 19; [Epub ahead of print]
- Oral pentoxifylline and pentavalent antimony for treatment of leishmaniasis: promising but inconclusive evidence of superiority, compared with antimony monotherapy.
Clin Infect Dis. 2007 Oct 15;45(8):1104; author reply 1005-6. No abstract available.
- Cryo-SEM studies of latex/ceramic nanoparticle coating microstructure development.
J Colloid Interface Sci. 2007 Jul 27; [Epub ahead of print]
- Synthesis, Structural Characterization, and Biological Studies of New Antimony(III) Complexes with Thiones. The Influence of the Solvent on the Geometry of the Complexes.
Inorg Chem. 2007 Sep 13; [Epub ahead of print]
- Ab initio calculations on low-lying electronic states of SbO(2) (-) and Franck-Condon simulation of its photodetachment spectrum.
J Chem Phys. 2007 Sep 7;127(9):094306.
- Low efficacy of azithromycin to treat cutaneous leishmaniasis in Manaus, AM, Brazil.
Rev Inst Med Trop Sao Paulo. 2007 Aug;49(4):235-238.
- Analytical procedure for the simultaneous voltammetric determination of trace metals in food and environmental matrices. Critical comparison with atomic absorption spectroscopic measurements.
Ann Chim. 2007 Mar-Apr;97(3-4):141-5
- Molecular mechanisms of antimony resistance in Leishmania.
J Med Microbiol. 2007 Feb;56(Pt 2):143-53.
- Speciation analysis of antimony in extracts of size-classified volcanic ash by HPLC-ICP-MS.
Anal Bioanal Chem. 2007 Jan 23; [Epub ahead of print]
- Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate.
J Infect Dis. 2007 Feb 15;195(4):602-8. Epub 2007 Jan 11.
- Circulating nitric oxide and C-reactive protein levels in Indian kala azar patients: Correlation with clinical outcome.
Clin Immunol. 2007 Jan 8; [Epub ahead of print]
- Use of handheld X-ray fluorescence spectrometry units for identification of arsenic in treated wood.
Environ Pollut. 2007 Jan 19; [Epub ahead of print]
- Prevention of aneuploidy by S-adenosyl-methionine in human cells treated with sodium arsenite.
Mutat Res. 2006 Dec 27; [Epub ahead of print]
- Arsenic bioaccessibility and speciation in clams and seaweed from a contaminated marine environment.
Mar Pollut Bull. 2007 Jan 20; [Epub ahead of print]
- Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells.
Food Chem Toxicol. 2006 Dec 13; [Epub ahead of print]
- Effect of arsenic on photosynthesis, growth and yield of five widely cultivated rice (Oryza sativa L.) varieties in Bangladesh.
Chemosphere. 2007 Jan 18; [Epub ahead of print]
- Arsenic recovery from water containing arsenite and arsenate ions by hydrothermal mineralization.
J Hazard Mater. 2006 Dec 15; [Epub ahead of print]
|
|